our brain tumor cocktails and stories
Pages
Home
User Information
Brain Tumor Library
Drug Interactions
Drug Dosing
Toxicities
Drug and Supplement sources
Handy links
Tuesday 29 August 2017
Results of the "failed" rindopepimut ACTIV trial published
Rindopepimut with temozolomide for patients with newlydiagnosed, EGFRvIII-expressing glioblastoma (ACT IV):a randomised, double-blind, international phase 3 trial
1 comment:
SoDoWarts
7 September 2017 at 10:39
This comment has been removed by the author.
Reply
Delete
Replies
Reply
Add comment
Load more...
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
This comment has been removed by the author.
ReplyDelete